NICOTINE TRANSDERMAL SYSTEM  STEP 3- nicotine patch, extended release 
NICOTINE TRANSDERMAL SYSTEM  STEP 2- nicotine patch, extended release 
NICOTINE TRANSDERMAL SYSTEM  STEP 1- nicotine patch, extended release 
Chain Drug Consortium, LLC

----------

NICOTINE TRANSDERMAL SYSTEM, STEP 1, STEP 2, STEP 3

Drug Fact

Active ingredient(in each patch)  

Step 1 - Nicotine, 21 mg delivered over 24 hours

Step 2 - Nicotine, 14 mg delivered over 24 hours

Step 3 - Nicotine, 7 mg delivered over 24 hours

Purpose

Stop smoking aid

Use

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking.

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider.Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Ask a doctor before use if you have

  • heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
  • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • an allergy to adhesive tape or have skin problems, because you are more likely to get rashes.

Ask a doctor or pharmacist before use if you are

  • using a non-nicotine stop smoking drug
  • taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

When using this product

  • do not smoke even when not wearing the patch. The nicotine in your skin will still be entering your blood stream for several hours after you take off the patch.
  • if you have vivid dreams or other sleep disturbances remove this patch at bedtime

Stop use and ask a doctor if

  • skin redness caused by the patch does not go away after four days, or if your skin swells, or you get a rash
  • irregular heartbeat or palpitations occur
  • you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness and rapid heartbeat

Keep out of reach of children and pets.

Used patches have enough nicotine to poison children and pets. If swallowed, get medical help or contact a Poison Control Center right away. Save pouch to use for patch disposal. Dispose of the used patches by folding sticky ends together and putting in pouch.

Directions

Other information  

store at 20 °C – 25 °C (68 °F – 77 °F)

Inactive ingredients

acrylate adhesive, polyester, silicone adhesive

Comments or Questions?

1-844-562-7963

TO INCREASE YOUR SUCCESS IN QUITTING: 

1. You must be motivated to quit.

2. Use one patch daily according to directions.

3. It is important to complete treatment.

4. If you feel you need to use the patch for a longer period to keep from smoking, talk to your health care provider.

5. Use patch with a behavioral support program such as the one described in the enclosed booklet.

PRINCIPAL DISPLAY PANEL - 7 mg CARTON

Nicotine Transdermal System

NDC No. 68016-290-88

14 Patches

7mgcarton.jpg

PRINCIPAL DISPLAY PANEL - 14 mg CARTON

Nicotine Transdermal System

NDC No. 68016-289-88

14 Patches

14mgcarton.jpg

PRINCIPAL DISPLAY PANEL- 21 mg CARTON

Nicotine Transdermal System

NDC No. 68016-288-88

14 Patches

21mgcarton.jpg

NICOTINE TRANSDERMAL SYSTEM   STEP 3
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-290
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE7 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-290-8814 in 1 CARTON10/20/1997
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/20/1997
NICOTINE TRANSDERMAL SYSTEM   STEP 2
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-289
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE14 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-289-8814 in 1 CARTON10/20/1997
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/20/1997
NICOTINE TRANSDERMAL SYSTEM   STEP 1
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-288
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE21 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE (UNII: 92RU3N3Y1O)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-288-8814 in 1 CARTON10/20/1997
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/20/1997
Labeler - Chain Drug Consortium, LLC (101668460)
Establishment
NameAddressID/FEIBusiness Operations
Aveva Drug Delivery Systems783982093manufacture(68016-288, 68016-289, 68016-290) , analysis(68016-288, 68016-289, 68016-290)

Revised: 2/2024
Document Id: 11b7496f-6483-00a4-e063-6394a90a0b41
Set id: 9b5ca2c9-de95-4800-a533-eaf6d5541cb8
Version: 8
Effective Time: 20240219
 
Chain Drug Consortium, LLC